Cereno Scientific AB (publ) (STO:CRNO.B)
Sweden
· Delayed Price · Currency is SEK 8.83
+0.18 (2.08%)
At close: May 8, 2025
Cereno Scientific AB Revenue
In the year 2024, Cereno Scientific AB had annual revenue of 80.90M SEK with 64.18% growth. Cereno Scientific AB had revenue of 11.58M in the quarter ending December 31, 2024, a decrease of -33.54%.
Revenue
80.90M
Revenue Growth
+64.18%
P/S Ratio
31.04
Revenue / Employee
16.18M
Employees
5
Market Cap
2.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.90M | 31.63M | 64.18% |
| Dec 31, 2023 | 49.28M | -8.26M | -14.36% |
| Dec 31, 2022 | 57.54M | 12.73M | 28.42% |
| Dec 31, 2021 | 44.81M | 36.58M | 444.85% |
| Dec 31, 2020 | 8.22M | 1.29M | 18.64% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Aug 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 997.85M |